Genomic fragment that encompasses RNaseZ (including its endogenous regulatory sequences). A T494I amino acid substitution has been introduced into the coding sequence. This change is equivalent to a T520I change in the orthologous human ELAC2 gene, a variant associated with cardiomyopathy. The coding sequence is tagged at C-terminal end with Tag:V5.
C10308125T
C1539T
T494I | RNaseZ-PB
T494I
Mutation in analagous codon in human ELAC2 implicated in cardiomyopathy associated with combined oxidative phosphorylation deficiency 17; mutation carried on in vitro construct; specific disease association inferred by FlyBase curator based on reported amino acid change.
RNaseZED24/RNaseZED24 individuals bearing 1 or two copies of RNaseZHCM1.Tag:V5 show a decreased climbing ability, as compared to controls; homozygotes bearing 1 copy of RNaseZHCM1.Tag:V5 show a thickened heart wall at the larval and adult stages; homozygotes bearing 1 copy of RNaseZHCM2.Tag:V5 show increased end-systolic area in larval and adult hearts, and increased end-diastolic area in larval hearts; homozygotes bearing 1 copy of RNaseZHCM2.Tag:V5 show decreased fractional shortening in the larval and adult heart. Muscle cells show increased number of nuclei with increased ploidy.
FBal0369461:, RNaseZED24 is partially rescued by RNaseZHCM2.Tag:V5/RNaseZHCM2.Tag:V5
RNaseZHCM2.Tag:V5 partially rescues RNaseZED24
RNaseZHCM2.Tag:V5/RNaseZHCM2.Tag:V5 partially rescues FBal0369461:, RNaseZED24